Whatsapp Hattımız
Prof.Dr. Abdullah İğci Medikal Onkoloji Uzmanı
Whatsapp Hattımız

Yabanci Dilde Makaleler

1.Özmen V, Martin PC, İğci A, Çevikbaş U, Webb WR:Adenocarcinoma of the gallbladder associated with congenital choledochal  cyst and anomalous pancreaticobiliary ductal junction. Euoropean Journal of Surgery, 157:549-551, 1991.

2. Özmen V, İğci A, Kebudi A, Keçer M, Bozfakıoğlu Y, Parlak M: Surgical treatment of hepatic hydatid dissease. Canadian Journal of Surgery, 35:423-427,1992.

3. Özmen V, Müslümanoğlu M, İğci A, Buğra D: Laparoscopic treatment of duodenal ulcer by bilateral truncal vagotomy and endoscopic balloon dilatation. Journal of Laparoendoscopic Surgery 5:21-26, 1995.

4. Müslümanoğlu M, Dolay K, Özmen V, İğci A, Bozfakıoğlu Y:Comparison of fine needle aspiration cytology and excisional biopsy in palpable breeeast cancers. La Radiologia Medica (Radiol Med ) 89:225-228, 1995.

5. Özaçmak İD, Özmen V, İğci A, Kebudi A: The effect of total preoperative total parenteral nutrition on delayed type hypersensitivity in anergic patients with gastrointestinal cancer.  Medical Bulletin of İstanbul Medical Faculty 2821-27, 1995.

6.İğci A, Berber E, Müslümanoğlu M, Bilir A, Özmen V, Güloğlu R, Bozfakioğlu Y, Dağoğlu, Keçer M: Thymidine labeling index  in breast cancer prognosis. The Breast Journal 4:41-49,1998.

7. Bilir A, Özmen V, Cabioğlu N, Müslümanoğlu M, Bozfakıoğlu Y, İğci  A, Aslay I, Aydıner A, Dağoğlu T, Erkan M: Dimethil sulfoxide synergistically increases the antitumor cytotoxicity of 5-FU on FMA-3 cell line cultures in tumor colony-forming assays. The Breast Journal 4(suppl.):54, 1998.

8.Cabioglu N, Dağoğlu T, Tuzlalı S, İğci A, Doğan O, Müslümanoğlu M, Özmen V,            Bozfakioğlu Y, Bilir A, Aydıner A, Keçer M, Parlak M : Predictive biological markers in evaluation of chemotherapy response in locally advanved breast cancer patients. 7th International Conference February 21-24, 2001 St Gallen / Switzerland The Breast, Adjuvant Therapy of Primary Breast Cancer Vol.10, Suppl.1, February 2001, Abstract book; S22, P28

9.Ozmen V, Cabioglu N, Dolay K, Bilir A, Kecer M, Aydiner A, Muslumanoglu M, Igci A, Bozfakioglu Y, Dagoglu T. Biological considerations in locally advanced breast cancer treated with anthracycline-based neoadjuvant chemotherapy: thymidine labelling index is an independent indicator of clinical outcome. Breast Cancer Res Treat 2001 Jul;68(2):147-57

10.Ozmen V, Muslumanoglu M, Cabioglu N, Tuzlali S, Ilhan R, Igci A, Kecer M, Bozfakioglu Y, Dagoglu T. : Increased false negative rates in sentinel lymph node biopsies in patients with multi-focal breast cancer. Breast Cancer Res Treat. 2002 Dec;76(3):237-44.
11.Cabioglu N, Igci A, Yildirim EO, Aktas E, Bilgic S, Yavuz E, Muslumanoglu M, Bozfakioglu Y, Kecer M, Ozmen V, Deniz G: An ultrasensitive tumor enriched flow-cytometric assay for detection of isolated tumor cells in bone marrow of patients with breast cancer. Am J Surg. 2002 Nov;184(5):414-7.

12.Ozmen V, Cabioglu N, Igci A, Dagoglu T, Aydiner A, Kecer M, Bozfakioglu Y, Dincer M, Bilir A, Topuz E: Inflammatory breast cancer : results of antracycline based chemotherapy. Breast J 2003 May-Apr; 9(2):79-85.

13.Asoglu O, Igci A, Karanlik H, Parlak M, Kecer M, Ozmen V, Muslumanoglu M: Laparoscopic treatment of mesenteric cysts. Surg Endosc 2003 May ; 17(5):832.

14.Asoglu O, İgci A, Karanlik H, Parlak M, Kecer M, Ozmen V, Muslumanoglu M: Laparoscopic treatment of mesenteric cysts. Surgical Endoscopy 17:831-34, 2003.

15.Asoglu O, Ozmen V, Karanlik H, Igci A, Kecer M, Parlak M, Unal ES. Does the complication rate increase in laparoscopic cholecystectomy for acute cholecystitis?
J Laparoendosc Adv Surg Tech . Apr;14(2):81-6, 2004.

16.Asoglu O, Ozmen V, Gorgun E, Karanlik H, Kecer M, Igci A, Unal ES, Parlak M. Does the early ligation of the splenic artery reduce hemorrhage during laparoscopic splenectomy? Surg Laparosc Endosc Percutan Tech 14(3): 118-21, 2004.

17.Ozmen V, Kaya H, Cabioglu N, Kecer M, Igci A: Increased lymph node positivity in multifocal breast cancer.  27th Annual San Antonio Breast Cancer Symposium, December  8-11, 2004, San Antonio, Texas. Breast Cancer Res Treat 88/Suppl 1, pp.S79  2004.

18.Avtan L, Avci C, Guvenc H, Igci A, Ozmen V. Laparoscopic myotomy for oesophageal achalasia–adding an antireflux procedure is not always necessary. Int J Clin Pract. 2005 Jan;59(1):35-8.

19.Asoglu O, Muslumanoglu M, Igci A, Ozmen V, Karanlik H, Ayalp K, Bozfakioglu Y, Kecer M, Parlak M : Breast conserving surgery after primary chemotherapy in locally advanced breast cancer. Acta Chir Belg. 2005 Feb;105(1):62-8.

20.Asoglu O, Ozmen V, Karanlik H, Tunaci M, Cabioglu N, Igci A, Selcuk UE, Kecer M. Feasibility of surgical management in patients with granulomatous mastitis. Breast J. 2005 Mar-Apr;11(2):108-14.
21.Ozmen V, Karanlik H, Cabioglu N, Igci A, Kecer M, Asoglu O, Tuzlali S, Mudun A. Factors predicting the sentinel and non-sentinel lymph node metastases in breast cancer. Breast Cancer Res Treat. 2006 Jan 95(1);:1-6

22.Ozmen V, Oran ES, Gorgun E, Asoglu O, Igci A, Kecer M, Dizdaroglu F. Histologic and clinical outcome after laparoscopic Nissen fundoplication for gastroesophageal reflux disease and Barrett’s esophagus.Surg Endosc. 2006 Feb;20(2):226-9.


23.Sanli Y, Berberoglu K, Turkmen C, Ozmen V, Muslumanoglu M, Igci A, Asoglu O, Kecer M, Tuzlali S, Cantez S, Mudun A. The Value of Combined Peritumoral and Subdermal Injection Techniques for Lymphoscintigraphy in Detection of Sentinel Lymph Node in Breast Cancer.Clin Nucl Med. 2006 Nov;31(11):690-693.

24.Asoglu O, Karanlik H, Muslumanoglu M, Igci A, Emek E, Ozmen V, Kecer M, Parlak M, Kapran Y. Prognostic and predictive factors after surgical treatment for locally recurrent rectal cancer: A single institute experience. Eur J Surg Oncol. 33(10):1199-206, 2007

25.Sen-Oran E, Ozmen V, Bilir A, Cabioglu N, Muslumanoglu M, Igci A, Guney N, Kecer M. Is the thymidine labeling index a good prognostic marker in breast cancer? World J Surg Oncol. 2007 Aug 19;5:93.

26.Mudun A, Sanli Y, Ozmen V, Turkmen C, Ozel S, Eroglu A, Igci A, Yavuz E, Tuzlali S, Muslumanoglu M, Cantez S. Comparison of different injection sites of radionuclide for sentinel lymph node detection in breast cancer: single institution experience.
Clin Nucl Med. 2008 Apr;33(4):262-7.

27.Asoglu O, Matlim T, Karanlik H, Atar M, Muslumanoglu M, Kapran Y, Igci A, Ozmen V, Kecer M, Parlak M. Impact of laparoscopic surgery on bladder and sexual function after total mesorectal excision for rectal cancer. Surg Endosc. 2008 Apr 9.

28.Derin D, Eralp Y, Ozluk Y, Yavuz E, Guney N, Saip P, Igci A, Ozmen V, Kucucuk S, Aslay I, Aydiner A, Topuz E. Lower Level of MAPK Expression is Associated with Anthracycline Resistance and Decreased Survival in Patients with Hormone Receptor Negative Breast Cancer. Cancer Invest. 2008 Jun 14:1.

29. Cabioglu N, Ozmen V, Kaya H, Tuzlali S, Igci A, Muslumanoglu M, Kecer M, Dagoglu T.Increased lymph node positivity in multifocal and multicentric breast cancer. J Am Coll Surg. 2009 Jan;208(1):67-74. Epub 2008 Oct 31.PMID: 19228505 [PubMed – indexed for MEDLINE]Related articles

30.Ozmen V, Ozcinar B, Karanlik H, Cabioglu N, Tukenmez M, Disci R, Ozmen T, Igci A, Muslumanoglu M, Kecer M, Soran A. Breast cancer risk factors in Turkish women—a University Hospital based nested case control study. World J Surg Oncol. 2009 Apr 8;7:37.PMID: 19356229 [PubMed – indexed for MEDLINE]Related articles Free article

31. Asoglu O, Karanlik H, Parlak M, Kecer M, Muslumanoglu M, Igci A, Ozmen V, Gulluoglu M, Kapran Y. Metastatic lymph node ratio is an independent prognostic factor in gastric cancer. Hepatogastroenterology. 2009 May-Jun;56(91-92):908-13.PMID: 19621727 [PubMed – indexed for MEDLINE]Related articles

32. Ozmen V, Unal ES, Muslumanoglu ME, Igci A, Canbay E, Ozcinar B, Mudun A, Tunaci M, Tuzlali S, Kecer M. Axillary sentinel node biopsy after neoadjuvant chemotherapy. Eur J Surg Oncol. 2009 Nov 18. [Epub ahead of print]PMID: 19931375 [PubMed – as supplied by publisher]Related articles

Email Telefon İletişim Formu Harita